Thermo Fisher Scientific Inc. (TMO) Stake Maintained by Starfire Investment Advisers Inc.
Starfire Investment Advisers Inc. held its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) during the second quarter, Holdings Channel reports. The fund owned 3,720 shares of the company’s stock at the end of the second quarter. Starfire Investment Advisers Inc.’s holdings in Thermo Fisher Scientific were worth $550,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of the company. Quadrant Capital Group LLC raised its stake in Thermo Fisher Scientific by 1.5% in the second quarter. Quadrant Capital Group LLC now owns 2,826 shares of the company’s stock valued at $410,000 after buying an additional 43 shares during the period. LMR Partners LLP bought a new stake in Thermo Fisher Scientific during the second quarter valued at $648,000. Papp L Roy & Associates raised its stake in Thermo Fisher Scientific by 3.3% in the second quarter. Papp L Roy & Associates now owns 43,038 shares of the company’s stock valued at $6,359,000 after buying an additional 1,394 shares during the period. Northpointe Capital LLC bought a new stake in Thermo Fisher Scientific during the second quarter valued at $2,401,000. Finally, Insight Capital Research & Management Inc. bought a new stake in Thermo Fisher Scientific during the second quarter valued at $2,638,000. Hedge funds and other institutional investors own 87.38% of the company’s stock.
Thermo Fisher Scientific Inc. (NYSE:TMO) traded down 0.15% during mid-day trading on Friday, hitting $158.21. The stock had a trading volume of 1,081,796 shares. The firm has a market capitalization of $62.38 billion, a price-to-earnings ratio of 31.65 and a beta of 0.97. Thermo Fisher Scientific Inc. has a one year low of $119.75 and a one year high of $160.68. The stock’s 50 day moving average price is $153.18 and its 200 day moving average price is $150.42.
Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Thursday, July 28th. The company reported $2.03 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.01 by $0.02. The business earned $4.54 billion during the quarter, compared to the consensus estimate of $4.50 billion. Thermo Fisher Scientific had a return on equity of 14.70% and a net margin of 11.35%. Thermo Fisher Scientific’s quarterly revenue was up 6.2% on a year-over-year basis. During the same period last year, the company earned $1.84 earnings per share. Analysts forecast that Thermo Fisher Scientific Inc. will post $8.17 EPS for the current year.
Several equities research analysts recently weighed in on the company. Bank of America Corp. set a $180.00 target price on Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Friday. JPMorgan Chase & Co. assumed coverage on Thermo Fisher Scientific in a report on Thursday, September 22nd. They issued an “overweight” rating and a $180.00 target price for the company. Cleveland Research lowered Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a report on Friday, September 9th. Zacks Investment Research lowered Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Friday, August 5th. Finally, Jefferies Group restated a “hold” rating on shares of Thermo Fisher Scientific in a report on Thursday, August 4th. Three research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $162.72.
In related news, VP Seth H. Hoogasian sold 5,023 shares of the stock in a transaction dated Wednesday, August 10th. The stock was sold at an average price of $156.00, for a total transaction of $783,588.00. Following the completion of the transaction, the vice president now directly owns 31,914 shares in the company, valued at $4,978,584. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Thomas W. Loewald sold 8,025 shares of the stock in a transaction dated Wednesday, July 13th. The stock was sold at an average price of $155.00, for a total value of $1,243,875.00. Following the transaction, the senior vice president now owns 52,194 shares of the company’s stock, valued at $8,090,070. The disclosure for this sale can be found here. Corporate insiders own 0.52% of the company’s stock.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.